AMLODIPINE AND OLMESARTAN MEDOXOMIL Drug Patent Profile
✉ Email this page to a colleague
When do Amlodipine And Olmesartan Medoxomil patents expire, and what generic alternatives are available?
Amlodipine And Olmesartan Medoxomil is a drug marketed by Accord Hlthcare Inc, Ajanta Pharma Ltd, Alembic, Alkem Labs Ltd, Aurobindo Pharma, Glenmark Pharms Ltd, Jubilant Generics, Macleods Pharms Ltd, Micro Labs, Sciegen Pharms Inc, Teva Pharms Usa, Torrent, and Zydus Pharms. and is included in thirteen NDAs.
The generic ingredient in AMLODIPINE AND OLMESARTAN MEDOXOMIL is amlodipine besylate; olmesartan medoxomil. There are fifty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; olmesartan medoxomil profile page.
Summary for AMLODIPINE AND OLMESARTAN MEDOXOMIL
US Patents: | 0 |
Applicants: | 13 |
NDAs: | 13 |
Finished Product Suppliers / Packagers: | 12 |
Clinical Trials: | 14 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in AMLODIPINE AND OLMESARTAN MEDOXOMIL? | AMLODIPINE AND OLMESARTAN MEDOXOMIL excipients list |
DailyMed Link: | AMLODIPINE AND OLMESARTAN MEDOXOMIL at DailyMed |
Recent Clinical Trials for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company | Phase 3 |
Daiichi Sankyo Korea Co., Ltd. | Phase 3 |
Torrent Pharmaceuticals Limited | Phase 1 |
Pharmacology for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Anatomical Therapeutic Chemical (ATC) Classes for AMLODIPINE AND OLMESARTAN MEDOXOMIL
US Patents and Regulatory Information for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa | AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 091154-001 | Oct 26, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Macleods Pharms Ltd | AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 206884-004 | Oct 26, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Zydus Pharms | AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 207771-001 | Sep 22, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |